Byterna is a biopharmaceutical

Byterna Therapeutics is a biopharmaceutical company headquartered in Shanghai, primarily focusing on circular mRNA (cmRNA) therapy and in vivo cmRNA CAR-T cell therapy. We utilize artificial intelligence (AI) to accelerate cmRNA design and employ targeted lipid nanoparticles (LNP) to deliver cmRNA cargo into T cells, generating CAR-T cells in vivo.